#Pharmaceutical Manufacturing
Browse all posts tagged with Pharmaceutical Manufacturing
The True Cost of a Failed Pharmaceutical Batch
April 15, 2026 • By Mike Barlow, Paul Van Buskirk
Most companies underestimate the true cost of a lost batch by 5–10×. Beyond the write-off, hidden work, capacity loss, and system disruption drive a much larger Cost of Poor Quality (COPQ) than is typically measured.
Digital Doesn’t Fix Broken Execution
April 8, 2026 • By Paul Van Buskirk
Pharmaceutical companies continue to invest heavily in digital transformation, yet operational outcomes remain unchanged. This article explains why visibility alone doesn’t improve execution—and how governance and discipline must come first.
Artificial Intelligence in GxP Environments
April 6, 2026 • By Paul Van Buskirk
Artificial Intelligence (AI) in GxP environments is not a decision-making system—it is structured decision support aligned with GAMP 5. Most organizations get this wrong, positioning AI in ways that introduce unnecessary compliance risk. This whitepaper defines the correct framework—how to apply AI with discipline, maintain human ownership of decisions, and align with regulatory expectations without increasing validation burden.
GMPWit™ Whitepaper | Structured Productivity in GMP Environments
March 19, 2026 • By Paul Van Buskirk, Mike Barlow
GMPWit™ introduces structured productivity to GMP environments, improving how deviation investigations, CAPAs, and operational work are created—without impacting validated systems or regulatory compliance.
Exposing the Hidden Factory: How COPQ Reveals Capacity Constraints
March 18, 2026 • By Mike Barlow
The Hidden Factory represents unmeasured capacity consumed by internal failure activities such as deviation investigations, production rework, and documentation errors. While these activities are tracked operationally, their economic impact is rarely quantified. Applying the Cost of Quality framework translates this consumption into financial terms, providing a basis for capacity recovery and risk-informed prioritization aligned with ICH Q9 and Q10.
BatchTrak™: Regulatory Alignment with ISPE and GAMP 5
March 16, 2026 • By Paul Van Buskirk, Mike Barlow
This whitepaper explains how the BatchTrak™ Manufacturing Operations Management platform aligns with ISPE Baseline Guide Volume 5 and GAMP 5 risk-based computerized system guidance for regulated pharmaceutical environments.